◼ Archived
Business
‘Zap, you’re gone.’ A Dana-Farber oncologist discusses the promising news on cancer vaccines.
Moderna and Merck's mRNA cancer vaccine reduces melanoma recurrence by 42% according to recent coverage.
Moderna
71 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
Moderna’s Cancer Vaccine Rally Hits a Wall. This Other Drugmaker Stole the Show.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Moderna CEO on what’s next after success in cancer vaccine
9 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
‘It is what it is’: Merck exec unruffled by ‘unfortunate’ leak of ESMO cancer vaccine data
Moderna's cancer vaccine shows a 42% reduction in melanoma recurrence in Phase 3 trial data leaked prior to ESMO.
◼ Archived
Business
Moderna mRNA vaccine almost halves the risk of skin cancer returning
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
First personalised cancer vaccine cuts risk of disease returning in major trial
A personalized mRNA cancer vaccine developed by Moderna and Merck cuts melanoma recurrence or death risk by 42%.
◼ Archived
Business
A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
Moderna stock extends recent market losses following the release of trial data concerning a novel mRNA melanoma vaccine.
◼ Archived
Business
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Moderna stock crashes as leaked melanoma data threatens its record August rally
Personalized mRNA cancer vaccine data shows significant reduction in melanoma recurrence and death rates.
◼ Archived
Health
Moderna (MRNA) Starts Late Stage Trial For mRNA Bird Flu Vaccine
Moderna has initiated a late-stage trial for an mRNA bird flu vaccine amid broader developments in influenza immunization options.
◼ Archived
Business
Moderna Cancer-Vaccine Data Leaks Early, Shares Plummet
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Moderna Crashes 20% On Reportedly Leaked Cancer Vaccine Data
Moderna shares tumble following a reported leak of cancer vaccine data involving melanoma treatments.
◼ Archived
Health
HealthLink: You're an older adult and need a flu shot. Which one to get?
Older adults and pharmacies navigate new mRNA options and availability questions for the current flu season.
◼ Archived
Business
Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Why Moderna Stock Surged Today
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Cancer Vaccines Are the N.I.H.’s Next ‘Big Bet’
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Moderna stock jumps on planned national cancer vaccine effort
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Why the FDA should not approve an ineffective multicancer screening test
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Exclusive | She was ready to die. Now she’s in remission
New developments in personalized mRNA cancer vaccines show promise for melanoma and breast cancer, though hurdles in public perception remain.
◼ Archived
Business
Moderna CEO’s Realistic Approach to Innovation
Moderna shares surge and track toward top September S&P 500 performance as markets eye upcoming clinical data.
◼ Archived
Business
Moderna Stock Hits a New High as CEO Says It’s More Than Covid Vaccines
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Dear Doctor: Is the new flu vaccine better enough to justify waiting for it?
The US has seen the launch of Moderna's mFlusiva, the first approved mRNA flu vaccine designed for specific older adult populations.
◼ Archived
Health
Cancer Vaccines Market Anticipates Impressive Growth Trajectory at a CAGR of 36% During the Forecast Period (2026-2036)
Recent coverage examines the growing cancer vaccines market alongside Phase 3 mRNA vaccine results and personalised medicine strategies.
◼ Archived
Business
Moderna Stock Jumps. Its mRNA Cancer Vaccine Is Getting Ready for Its Next Big Test.
Moderna shares surge toward a 52-week high as upcoming melanoma vaccine data commands attention at the ESMO Congress.
◼ Archived
Health
The first mRNA flu shot is now available. Here’s who can get it.
Moderna's first mRNA flu vaccine has received FDA approval and is now available for older adults ahead of the 2026 flu season.
◼ Archived
Business
Dow Jones Futures: S&P 500, Nasdaq Rebound Above Key Level; Moderna, AMD, SpaceX Flash Buy Signals
Dow futures point to a rebound in S&P 500 and Nasdaq above key levels, while Moderna, AMD and SpaceX flash buy signals spark trader interest.
◼ Archived
Health
Flu season is coming: What to know about new vaccine, when to get your shot and more
A newly approved mRNA flu shot for adults 50+ is rolling out at CVS, Walgreens and local pharmacies as the 2026 flu season approaches.
◼ Archived
Business
🔮 fades ✗
Dow Jones Futures: Fed Rate Hike Seen As Oil, Yields Pressure Stocks; Apple, Moderna Are New Buys
Dow Jones futures face pressure as anticipation of a Federal Reserve rate hike coincides with rising oil prices and yields.
◼ Archived
Business
🔮 fades ✓
Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?
Moderna and Merck trial data sparks debate over whether a personalized medicine revolution is beginning.
◼ Archived
Health
🔮 fades ✗
What to know about the new mRNA flu vaccine
Health coverage highlights FDA approval of Moderna's new mRNA flu vaccine and emerging studies on broader antibody responses.
◼ Archived
Business
🔮 holds ✗
Personalized mRNA cancer vaccines offer new hope. We explain
Personalized mRNA cancer vaccines are gaining momentum following Phase III success in melanoma and expanded global clinical trials.
◼ Archived
Business
🔮 fades ✓
Moderna Rises 6% Despite GSK Moving Rival mRNA Flu Vaccine to Phase III
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
GSK catches phase 3 fever after mRNA flu vaccine beats standard shots
GSK advances its mRNA flu vaccine candidate to phase 3 trials following successful mid-stage performance data.
◼ Archived
Business
🔮 fades ✓
There’s a big change for this year’s flu shot: When should you be vaccinated?
GSK is advancing a new mRNA flu vaccine to Phase III trials after the candidate outperformed standard vaccinations in earlier testing.
◼ Archived
Business
🔮 fades ✓
23 best-performing stocks of August, as the software industry continues its recovery
Wall Street closed August with gains driven by an unusual set of winners and a continued recovery within the software industry.
◼ Archived
Business
🔮 fades ✓
BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 test
BioNTech and Genentech have terminated a phase 2 mRNA colorectal cancer vaccine trial after safety reviews revealed more deaths than in the control group.
◼ Archived
Business
🔮 fades ✗
What to Know About New Covid Vaccines for Fall 2026
FDA clears new Moderna and XFG‑Adapted COVID shots for fall 2026 as cases climb, prompting fresh media focus on seasonal protection.
◼ Archived
Business
🔮 fades ✗
The mystery of Moderna’s magic algorithm
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Meta, Nvidia, Intuit, Salesforce, Moderna, Abercrombie, Zoom, and More Stocks That Explain Today’s Market
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
Moderna’s Cancer Vaccine Gives Stock a New Growth Story. Will It Have a Happy Ending?
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
What it was like to go through a trial that could revolutionize cancer treatment
Moderna and Merck have reported a significant triumph regarding a collaborative cancer vaccine trial that could revolutionize oncology treatment.
◼ Archived
Business
🔮 fades ✓
There’s a new type of flu vaccine for older adults this year. Can you get it?
The FDA has approved Moderna's mRNA-based flu vaccine, marking a shift in immunization technology for older adults.
◼ Archived
Business
🔮 fades ✓
It now seems possible to vaccinate against cancer
Advancements in mRNA technology are driving the development of cancer vaccines, specifically targeting melanoma and expanding medical breakthroughs.
◼ Archived
Business
🔮 fades ✓
Moderna, Merck breakthrough could usher in wave of cancer vaccines
11 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Moderna Stock Is Just The Start: Why AI-Focused Money Might Flow Into Biotech
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Quant hedge funds suffer worst day in 2 years as Treasury boosts buyback and Moderna shares leap
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Stocks making the biggest moves premarket: Walmart, Coinbase, Moderna, Alibaba & more
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
Why Is Moderna Stock Down Today?
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Moderna and Merck’s mRNA Melanoma Vaccine Looks Like a Game Changer
Moderna and Merck's mRNA melanoma vaccine is drawing significant attention as a potential game changer according to recent coverage.
◼ Archived
Business
🔮 fades ✓
New mRNA vaccine could reduce the recurrence and spread of skin cancer
Recent trial results for an mRNA vaccine developed by Moderna point toward a potential shift in future cancer care.
◼ Archived
Business
🔮 fades ✓
After Moderna stock surge of 177% on cancer drug breakthrough, here's what Wall Street thinks happens next
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Wall St recovers as yields ease; Moderna lifts healthcare stocks
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Wall St up after tech selloff as yields retreat; Moderna surges
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
Moderna Shares Double on Success of mRNA Cancer Vaccine
Moderna shares double following clinical trial results for a personalized mRNA melanoma vaccine developed with Merck.
◼ Archived
Business
🔮 fades ✓
Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
Merck and Moderna’s melanoma vaccine hits key survival milestones, sending Moderna's stock soaring.
◼ Archived
Business
🔮 fades ✓
Moderna surges as Merck-partnered melanoma vaccine cuts recurrence in large trial
Moderna stock surges after a partnered melanoma vaccine developed with Merck successfully reduced cancer recurrence in a large-scale clinical trial.
◼ Archived
Business
🔮 fades ✗
Moderna shares soar 60% on melanoma vaccine trial success
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 holds ✓
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
Moderna and Merck report success in a late-stage melanoma trial for their personalized mRNA cancer vaccine.
◼ Archived
Health
🔮 fades ✓
‘Mismatched’ vaccine being rolled out against Ebola outbreak
Health authorities and global outlets report ongoing rollout discussions and upcoming trials for Ebola vaccines in the DRC.